BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31869560)

  • 1. Antimicrobial resistance and antibiotic consumption in Mexican hospitals.
    Miranda-Novales MG; Flores-Moreno K; López-Vidal Y; Rodríguez-Álvarez M; Solórzano-Santos F; Soto-Hernández JL; Ponce de León-Rosales S;
    Salud Publica Mex; 2020; 62(1):42-49. PubMed ID: 31869560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
    Zhang F; Li Y; Lv Y; Zheng B; Xue F
    J Glob Antimicrob Resist; 2019 Jun; 17():276-282. PubMed ID: 30611932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility testing and antibiotic consumption results from 16 hospitals in Viet Nam: The VINARES project 2012-2013.
    Vu TVD; Do TTN; Rydell U; Nilsson LE; Olson L; Larsson M; Hanberger H; Choisy M; Dao TT; van Doorn HR; Nguyen VK; Nguyen VT; Wertheim HFL;
    J Glob Antimicrob Resist; 2019 Sep; 18():269-278. PubMed ID: 31201995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.
    Iosifidis E; Antachopoulos C; Tsivitanidou M; Katragkou A; Farmaki E; Tsiakou M; Kyriazi T; Sofianou D; Roilides E
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):615-22. PubMed ID: 18624668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017.
    Ismail H; Lowman W; Govind CN; Swe Swe-Han K; Maloba MRB; Bamford C; Perovic O
    S Afr Med J; 2019 Nov; 109(12):934-940. PubMed ID: 31865955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011.
    Wong PH; von Krosigk M; Roscoe DL; Lau TT; Yousefi M; Bowie WR
    BMC Infect Dis; 2014 Oct; 14():393. PubMed ID: 25308184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli.
    De Socio GV; Rubbioni P; Botta D; Cenci E; Belati A; Paggi R; Pasticci MB; Mencacci A
    J Glob Antimicrob Resist; 2019 Dec; 19():154-160. PubMed ID: 31112804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
    Hwang H; Kim B
    Sci Rep; 2018 Oct; 8(1):14757. PubMed ID: 30283084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance of gram-negative bacteria: A six-year longitudinal study in a hospital in Saudi Arabia.
    Al-Tawfiq JA; Rabaan AA; Saunar JV; Bazzi AM
    J Infect Public Health; 2020 May; 13(5):737-745. PubMed ID: 32008927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in
    Cusini A; Herren D; Bütikofer L; Plüss-Suard C; Kronenberg A; Marschall J
    Antimicrob Resist Infect Control; 2018; 7():89. PubMed ID: 30069305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study.
    Seifert H; Blondeau J; Dowzicky MJ
    Int J Antimicrob Agents; 2018 Oct; 52(4):474-484. PubMed ID: 30012439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
    Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group
    Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial susceptibility and prevalence of beta-lactamase producing clinical isolates in southern Kyushu. The results of collaborative study from 1999 to 2000].
    Nakasone I; Onaga S; Fukunaga H; Saitoh H; Yamane N; Sato Y
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():95-110. PubMed ID: 12599533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
    Guo W; He Q; Wang Z; Wei M; Yang Z; Du Y; Wu C; He J
    Am J Infect Control; 2015 Apr; 43(4):358-64. PubMed ID: 25838134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
    Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
    J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.